NDC 66992-430

Conjupri

Levamlodipine

Conjupri is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Wraser Llc. The primary component is Levamlodipine Maleate.

Product ID66992-430_de229406-ef83-70e5-e053-2995a90ae939
NDC66992-430
Product TypeHuman Prescription Drug
Proprietary NameConjupri
Generic NameLevamlodipine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-08-15
Marketing CategoryNDA /
Application NumberNDA212895
Labeler NameWraSer LLC
Substance NameLEVAMLODIPINE MALEATE
Active Ingredient Strength5 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 66992-430-30

30 TABLET in 1 BOTTLE (66992-430-30)
Marketing Start Date2021-08-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Conjupri" or generic name "Levamlodipine"

NDCBrand NameGeneric Name
24075-0410Conjuprilevamlodipine
24075-0411Conjuprilevamlodipine
24075-0412Conjuprilevamlodipine
24075-0413Conjuprilevamlodipine
66992-425Conjuprilevamlodipine
66992-430Conjuprilevamlodipine
69101-512Conjuprilevamlodipine maleate
69101-525Conjuprilevamlodipine maleate
69101-550Conjuprilevamlodipine maleate
42195-425Levamlodipinelevamlodipine
42195-450Levamlodipinelevamlodipine

Trademark Results [Conjupri]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CONJUPRI
CONJUPRI
88716966 not registered Live/Pending
Conjupro Biotherapeutics Inc.
2019-12-05
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.